Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Pascale Witz
AddedMar 31, 2024
UpdatedMay 31, 2026
Pascale Witz

Pascale Witz

Board Member, Fresenius Medical Care

LinkedIn

Pascale Witz's Career

Fresenius Medical Care
Fresenius Medical Care

Bad Homburg vor der Höhe, Hesse, DE

Board Member· Board
Regulus Therapeutics
Regulus Therapeutics

San Diego, CA, US

Board Member· Board
Revvity
Revvity

Waltham, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Pascale Witz's Career

Fresenius Medical Care
Fresenius Medical Care
Public$182.7M128k1996Bad Homburg vor der Höhe, Hesse, DE
Board Member· Board

Leadership at Fresenius Medical Care

Eduard FreseniusEduard FreseniusFounder
Rolf ClassonRolf ClassonBoard Member
Dr. Katarzyna MazurDr. Katarzyna MazurBoard Member
Helen GizaHelen GizaBoard Member
Sara HennickenSara HennickenBoard Member
Dorothea WenzelDorothea WenzelBoard Member

Similar to Fresenius Medical Care

Fresenius Medical Care North AmericaFresenius Medical Care North AmericaWaltham, MA, USDialysis Care, Productsest. 1996Fresenius Medical Care North AmericaWaltham, MA, US · est. 1996

Waltham-based FMS ENA Home offers quality dialysis for improved health and life.

Public · $99.7M30
Fresenius Medical Care Cedar HillFresenius Medical Care Cedar HillCookeville, TN, USDialysis, Treatmentest. 2017Fresenius Medical Care Cedar HillCookeville, TN, US · est. 2017

Leading medical organization in Waltham, MA, offering dialysis treatment and support for chronic kidney disease.

Public · $24.6M5
DaVitaDaVitaDenver, CO, USDialysis, Healthcareest. 1994DaVitaDenver, CO, US · est. 1994

US-based DaVita Inc. offers global kidney dialysis services for chronic kidney failure patients.

Public · $750M70k
Fresenius Vascular CareFresenius Vascular CareBerwyn, PA, USDialysis, Vascular Careest. 2005Fresenius Vascular CareBerwyn, PA, US · est. 2005

Fresenius Vascular Care, a leading provider of dialysis services & products, offers high-quality, accessible healthcare with innovative, minimally invasive therapies.

Series A · $23.9M750
Regulus Therapeutics
Regulus Therapeutics
Public$380.9M302007San Diego, CA, US
Board Member· Board

Leadership at Regulus Therapeutics

Kathryn J CollierKathryn J CollierBoard Member
Simos SimeonidisSimos SimeonidisBoard Member
William H. RastetterWilliam H. RastetterBoard Member
Stelios PapadopoulosStelios PapadopoulosBoard Member
Jay HaganJay HaganBoard Member
Jake NunnJake NunnBoard Member

Similar to Regulus Therapeutics

Regel TherapeuticsRegel TherapeuticsBoston, MA, USGene TherapyRegel TherapeuticsBoston, MA, US

Regel Therapeutics: Revolutionizing gene therapy and transforming patient outcomes with unique technology.

Pre-Seed · $1M14
Regor TherapeuticsRegor TherapeuticsBoston, MA, USBiotechnologyest. 2018Regor TherapeuticsBoston, MA, US · est. 2018

Regor: A global biotech leader innovating in oncology, metabolic and autoimmune diseases.

Series D · $140M8
Regulonix HoldingRegulonix HoldingTucson, AZ, USPain Treatmentsest. 2017Regulonix HoldingTucson, AZ, US · est. 2017

Regulonix: A biotech firm innovating non-opioid, chronic pain treatments via NaV1.7 channel targeting.

Seed · $2M8
Ionis PharmaceuticalsIonis PharmaceuticalsCarlsbad, CA, USPharmaceuticalsest. 1989Ionis PharmaceuticalsCarlsbad, CA, US · est. 1989

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Public · $1.3B796
Revvity
Revvity
Public16.7k1937Waltham, MA, US
Board Member· Board

Leadership at Revvity

Sylvie GrégoireSylvie GrégoireBoard Member
Charles ElmerCharles ElmerCo-Founder
Richard PerkinRichard PerkinCo-Founder
Prahlad R SinghPrahlad R SinghBoard Member

People Similar to Pascale Witz

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao